Showing 40,121 - 40,140 results of 100,247 for search '(( 5 step decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.65s Refine Results
  1. 40121

    The Carbon Nanotubes Effect into Single-lap Joint Failure Modes and Load Capacity: a Macromechanical Analysis by Elvis Carneiro Monteiro (4791726)

    Published 2018
    “…The results showed that the addition of 1.0 wt% CNTs improved the interface strength, leading to an increase on delaminated areas in failure region up to 55.36% and also improving the peak force up to 13.85%. Decrease in adhesive thickness from 0.40 mm to 0.05 mm promoted a stress redistribution inside adhesive layer improving the peak force up to 13.91%. …”
  2. 40122

    The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data by The WorldWide Antimalarial Resistance Network (WWARN) DP Study Group (614261)

    Published 2013
    “…After adjusting for confounding factors, the mg/kg dose of piperaquine was found to be a significant predictor for recrudescence, the risk increasing by 13% (95% CI 5.0%–21%) for every 5 mg/kg decrease in dose; <i>p</i> = 0.002. …”
  3. 40123

    S3 File - by Jens Panse (350046)

    Published 2024
    “…<div><p>Background</p><p>Although complement component 5 inhibitors (C5is) eculizumab and ravulizumab improve paroxysmal nocturnal hemoglobinuria (PNH) outcomes, patients may experience persistent anemia. …”
  4. 40124

    S2 File - by Jens Panse (350046)

    Published 2024
    “…<div><p>Background</p><p>Although complement component 5 inhibitors (C5is) eculizumab and ravulizumab improve paroxysmal nocturnal hemoglobinuria (PNH) outcomes, patients may experience persistent anemia. …”
  5. 40125

    Overview of the post hoc analysis. by Jens Panse (350046)

    Published 2024
    “…<div><p>Background</p><p>Although complement component 5 inhibitors (C5is) eculizumab and ravulizumab improve paroxysmal nocturnal hemoglobinuria (PNH) outcomes, patients may experience persistent anemia. …”
  6. 40126

    S1 File - by Jens Panse (350046)

    Published 2024
    “…<div><p>Background</p><p>Although complement component 5 inhibitors (C5is) eculizumab and ravulizumab improve paroxysmal nocturnal hemoglobinuria (PNH) outcomes, patients may experience persistent anemia. …”
  7. 40127

    Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study by Lena Björck (77400)

    Published 2016
    “…We assumed that there would be moderate improvements in smoking (5%), salt intake (1g/day) and physical inactivity (5% decrease) to continue recent, positive trends.…”
  8. 40128

    Table1_Does autoimmune diseases increase the risk of frailty? A Mendelian randomization study.doc by Jinlei Zhou (8250663)

    Published 2024
    “…Conversely, MS appears to be associated with a potential decrease in the risk of frailty.</p>…”
  9. 40129

    A qualitative exploration of Australian eyecare professional perspectives on Age-Related Macular Degeneration (AMD) care by Isabelle Jalbert (7356386)

    Published 2020
    “…Participants individually ranked their perceived top five barriers and enablers with the most important granted a score of 5 and the least important a score of 1. …”
  10. 40130

    Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease by Ana Yecê das Neves Pinto (415537)

    Published 2013
    “…Added, there was evidence of therapeutic failure immediately following treatment, as demonstrated by xenodiagnosis and blood culture methods in 2.3% and 3.5% of cases, respectively. There was a strong evidence of antibody clearing in the fourth year after treatment and continuous decrease of antibody titers. …”
  11. 40131

    Deletion of Msh2 in medium-spiny neurons delays nuclear huntingtin phenotypes. A, B. by Marina Kovalenko (136557)

    Published 2012
    “…<p>Nuclear mutant huntingtin immunostaining is decreased in the striata of five-month old <i>HdhQ111</i>/+ mice with deletion of <i>Msh2</i> in MSNs. …”
  12. 40132
  13. 40133
  14. 40134
  15. 40135
  16. 40136

    Effects of MβCD and MβCD + cholesterol on intracellular calcium. by Mohammed Z. Haque (3148443)

    Published 2016
    “…<p>(5A) Diastolic and systolic Fluo-4 fluorescence values. (5B) Maximal rate of Fluo-4 increase during systole, and (5C) maximal rate of Fluo-4 decrease during diastole. * p<0.05 vs. control, n = 20–30/group.…”
  17. 40137

    MitoNEET plays a role for oxidative stress induced apoptosis in cardiac HL-1 cells. by Anika Habener (3165984)

    Published 2016
    “…(C,D) Overexpression of mitoNEET in HL-1 cells caused a significant decrease in apoptosis in mitoNEET overexpressing cells compared to H/R control cells. …”
  18. 40138

    Table_1_Knowledge and Response to Stroke Among Lebanese Adults: A Population-Based Survey.DOCX by Sylvia Saade (12749600)

    Published 2022
    “…</p>Results<p>The mean SKT score of the participants was 9.16. 48.5% showed a poor stroke-related knowledge level and 51.5% a good knowledge level. …”
  19. 40139

    Limb Immobilization Induces a Coordinate Down-Regulation of Mitochondrial and Other Metabolic Pathways in Men and Women by Arkan Abadi (261229)

    Published 2009
    “…There was also a significant decrease in the protein content of mitochondrial cytochrome <em>c</em> oxidase, and the enzyme activity of cytochrome <em>c</em> oxidase and citrate synthase after 14 D of immobilization. …”
  20. 40140

    Measuring therapy-induced tumor hypoxia in A549 non-small cell lung cancer xenografts. by Needa A. Virani (9167479)

    Published 2020
    “…The AuNP+IR group showed a 2.5-fold increase (**<i>P<0</i>.<i>05</i>) at 48 h post-IR and then a decrease to the level of IR-only signal 11 days later. …”